CORTEXA
← Browse
arxivcs.AIq-bio.QMstat.AP2026-06-27

Expert Evaluation of Clinical AI Tools on Real Point-of-Care Clinical Queries

Jean Feng, Vishal Patel, Patrick Heagerty, Yifan Mai, Venkatesh Sivaraman, Patrick Vossler, Jialin Ouyang, Anupam B. Jena

Physicians now pose millions of clinical questions to AI tools each week, yet these tools are evaluated largely on hypothetical or exam-style questions, not those actually asked in practice. We report a blinded evaluation built on 620 Real-world Point-Of-Care Queries (Real-POCQi) submitted to the OpenEvidence (OE) platform by physicians spanning 30 specialties, as well as 187 questions from HealthBench. 149 practicing physicians across 36 states made head-to-head comparisons between answers from three frontier general-purpose models (Claude Opus 4.8, Gemini 3.1 Pro, and GPT-5.5) and a specialized clinical tool (OE), with graders matched to each question's specialty. When comparing answers along five dimensions relevant to clinical decision support -- accuracy, clinical utility, source quality, verifiability, & completeness -- physicians scored the specialized tool highest on all axes; in the primary analysis on Real-POCQi, win differences (margins between win and loss rates) ranged from 25 to 39 percentage points (p<0.001). Results remained consistent in sensitivity analyses stratifying by citation display, answer length, OE-user status, and Real-POCQi versus HealthBench. In parallel, LLM judges were found to systematically differ from expert judges, though both generally agreed on the best model. These findings underscore two conclusions: (i) AI tool evaluations should reflect real-world query distributions and use expert judges that mirror the specialization defining modern medicine and (ii) the consistent advantage of the specialized tool over general-purpose models does not necessarily mean that the latter cannot serve similar purposes, but that targeted engineering and customization can yield meaningful gains in performance for its users. We release Real-POCQi as a public benchmark, as well as the prespecified statistical analysis for reproducing results of this study.

View free PDFSource page

Related papers

arxivcs.CLcs.AIq-bio.QM2026-06-29

Clinical Reasoning Graphs: Structured Evaluation of LLM Diagnostic Reasoning Reveals Competence Without Consistency

Nisarg A. Patel

Modern large language models (LLMs) reach 60-70% diagnostic accuracy on complex clinical case benchmarks, but accuracy alone cannot distinguish stable clinically-grounded reasoning from pattern matching. We introduce clinical reasoning graphs, structured graph representations ext…

View free PDFSource page
arxivcs.CRcs.AIstat.AP2026-06-26

Agentic AI-Powered Re-Identification: An Emerging, Scalable Threat to Mobility Microdata Privacy

Oscar Thees, Roman Müller, Matthias Templ

The widespread collection of fine-grained location data by commercial data brokers creates a re-identification risk that is not widely recognised by the public. While prior research has established that mobility traces are highly unique and that individuals can, in principle, be…

View free PDFSource page
arxivstat.APcs.AIcs.LG2026-07-18

Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects

Xiaodi Li, Munhuwan Lee, Pengyang Li, Xiaoke Liu, Jose K. James, Patricia A. Pellikka, et al.

Traditional randomized trials often obscure clinically meaningful heterogeneity in treatment response by focusing on average effects. Leveraging real-world data to emulate clinical trials and estimate heterogeneous treatment effects (HTEs) offers a promising path toward more prec…

View free PDFSource page
arxivcs.LGcs.AIcs.IRq-bio.QM2026-07-21

Biological Amnesia in ICU Time-Series Prediction: A Drift-Adaptive Two-Stream Architecture with Temporal Retrieval

Fatema Ferdous Tamanna, K. M. Merajul Arefin, Md. Abdul Masud

Background: Clinical decision support systems degrade silently as treatment protocols evolve, yet standard adaptation methods treat models as monolithic blocks, unable to distinguish stable patient physiology from shifting institutional practice. Methods: We propose an adaptive c…

View free PDFSource page
arxivq-bio.QMcs.AIcs.LG2026-07-09

DrugGen 2: A disease-aware language model for enhancing drug discovery

Ali Motahharynia, Mohammadreza Ghaffarzadeh-Esfahani, Mahsa Sheikholeslami, Navid Mazrouei, Matin Irajpour, Yousof Gheisari, et al.

Current computational approaches for drug design typically focus on generating molecules conditioned on specific targets or general molecular properties, often neglecting the influence of disease context on target behavior and therapeutic outcomes. To address this gap, we introdu…

View free PDFSource page